Abiopharma

New Form 4 - Journey Medical Corp Filed: 2025-06-20 AccNo: 0001104659-25-061156 Size: 7 KB

New Form 4 - ANAPTYSBIO, INC Filed: 2025-06-20 AccNo: 0001415889-25-017819 Size: 5 KB

New Form 4 - Cencora, Inc. Filed: 2025-06-20 AccNo: 0001140859-25-000109 Size: 4 KB

New Form S-8 - Adverum Biotechnologies, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143640 Size: 236 KB

New Form 8-K - SOLIGENIX, INC. Filed: 2025-06-20 AccNo: 0001558370-25-008772 Size: 658 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form S-8 - Mind Medicine Filed: 2025-06-20 AccNo: 0001104659-25-061150 Size: 197 KB

New Form 4 - Journey Medical Corp Filed: 2025-06-20 AccNo: 0001104659-25-061155 Size: 7 KB

New Form 11-K - ABBOTT LABORATORIES Filed: 2025-06-20 AccNo: 0001104659-25-061154 Size: 1 MB

New Form 4 - 4D Molecular Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088497 Size: 5 KB

New Form 8-K - Aptevo Therapeutics Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088494 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - ARGENX SE Filed: 2025-06-20 AccNo: 0001104659-25-061153 Size: 47 KB

New Form 8-K - Repare Therapeutics Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143639 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form D - Indaptus Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015841 Size: 18 KB

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’sAtaxia

New Form 4 - Akari Therapeutics Plc Filed: 2025-06-20 AccNo: 0000950170-25-088490 Size: 4 KB